The Morphogenesis Scientific Advisory Board is composed of scientists who are internationally recognized in their fields. Their backgrounds range from academia to industry, from gene targeting to medical devices. This scope of expertise gives Morphogenesis a competitive advantage in developing its broad range of cellular technologies.

As Morphogenesis technologies enter the clinical development stage, the Medical Advisory Board will continue to grow and its importance increase. As evidenced by the superlative representatives from the medical community already on the Board, the Company's intention is to recruit stellar advisors with relevant expertise for this critical aspect of product development.